Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Racial Differences in Systemic Immune Parameters in Individuals With Lung Cancer.
von Itzstein MS, Liu J, Mu-Mosley H, Fattah F, Park JY, SoRelle JA, Farrar JD, Gwin ME, Hsiehchen D, Gloria-McCutchen Y, Wakeland EK, Cole S, Bhalla S, Kainthla R, Puzanov I, Switzer B, Daniels GA, Zakharia Y, Shaheen M, Zhang J, Xie Y, Gerber DE. von Itzstein MS, et al. Among authors: kainthla r. JTO Clin Res Rep. 2024 Oct 19;6(1):100751. doi: 10.1016/j.jtocrr.2024.100751. eCollection 2025 Jan. JTO Clin Res Rep. 2024. PMID: 39619775 Free PMC article.
Differences in systemic immune parameters in individuals with lung cancer according to race.
von Itzstein MS, Liu J, Mu-Mosley H, Fattah F, Park JY, SoRelle JA, Farrar JD, Gwin ME, Hsiehchen D, Gloria-McCutchen Y, Wakeland EK, Cole S, Bhalla S, Kainthla R, Puzanov I, Switzer B, Daniels GA, Zakharia Y, Shaheen M, Zhang J, Xie Y, Gerber DE. von Itzstein MS, et al. Among authors: kainthla r. bioRxiv [Preprint]. 2024 Jun 10:2024.06.07.597754. doi: 10.1101/2024.06.07.597754. bioRxiv. 2024. Update in: JTO Clin Res Rep. 2024 Oct 19;6(1):100751. doi: 10.1016/j.jtocrr.2024.100751 PMID: 38915535 Free PMC article. Updated. Preprint.
The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial.
Hsiehchen D, Beg MS, Kainthla R, Lohrey J, Kazmi SM, Khosama L, Maxwell MC, Kline H, Katz C, Hassan A, Kubota N, Siglinsky E, Pillai AK, Youssoufian H, Mockbee C, Culm K, Uhlik M, Benjamin L, Brekken RA, Ahn C, Singal AG, Zhu H, Hoshida Y, Yopp AC. Hsiehchen D, et al. Among authors: kainthla r. Nat Commun. 2024 Mar 11;15(1):2178. doi: 10.1038/s41467-024-46542-y. Nat Commun. 2024. PMID: 38467639 Free PMC article. Clinical Trial.
Characteristics and clinical outcomes in young-onset cholangiocarcinoma.
Reddy S, Goksu SY, Sanford NN, Kainthla R, Hsiehchen D, Sanjeevaiah A, Jones AL, Karagkounis G, Al Mutar S, Ahn C, Beg MS, Kazmi SM. Reddy S, et al. Among authors: kainthla r. Cancer Med. 2023 Jul;12(13):14094-14103. doi: 10.1002/cam4.6063. Epub 2023 May 22. Cancer Med. 2023. PMID: 37212509 Free PMC article.
High Seroprevalence of Kaposi Sarcoma-Associated Herpesvirus in Men Who Have Sex With Men With HIV in the Southern United States.
Knights SM, Salyards M, Kendall N, Lazarte SM, Kainthla R, Miley W, Marshall V, Labo N, Whitby D, Chiao EY, Nijhawan AE. Knights SM, et al. Among authors: kainthla r. Open Forum Infect Dis. 2023 Mar 24;10(4):ofad160. doi: 10.1093/ofid/ofad160. eCollection 2023 Apr. Open Forum Infect Dis. 2023. PMID: 37096147 Free PMC article.
29 results